HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Brière Selected Research

LNH87-2 protocol

8/2000Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Brière Research Topics

Disease

7Lymphoma (Lymphomas)
05/2017 - 03/2000
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2017 - 03/2008
4Neoplasms (Cancer)
05/2017 - 05/2000
4Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2015 - 08/2000
3Hodgkin Disease (Hodgkin's Disease)
01/2014 - 03/2001
1Hypoxia (Hypoxemia)
05/2015
1Epstein-Barr Virus Infections
01/2014
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2008
1Polycythemia Vera
10/2004
1Mastocytosis
06/2004
1Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2004
1Systemic Mastocytosis
06/2004
1Sarcoidosis (Schaumann Disease)
10/2002
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2002
1Essential Thrombocythemia
06/2001
1Hepatocellular Carcinoma (Hepatoma)
02/2001
1Thrombosis (Thrombus)
02/2001
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
02/2001
1Necrosis
02/2001
1Celiac Disease (Celiac Sprue)
07/2000

Drug/Important Bio-Agent (IBA)

5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2013 - 03/2000
4Prednisone (Sone)FDA LinkGeneric
04/2013 - 03/2000
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013 - 03/2000
3Bleomycin (Blenoxane)FDA LinkGeneric
04/2013 - 03/2000
3Etoposide (VP 16)FDA LinkGeneric
11/2008 - 03/2000
2ParaffinIBA
05/2017 - 07/2000
2Vindesine (Vindesin)IBA
04/2013 - 03/2000
2Rituximab (Mabthera)FDA Link
04/2013 - 10/2008
2Vincristine (Oncovin)FDA LinkGeneric
11/2008 - 10/2008
2Cytarabine (Cytosar-U)FDA LinkGeneric
06/2004 - 08/2000
2InterferonsIBA
06/2004 - 04/2002
2Methotrexate (Mexate)FDA LinkGeneric
10/2002 - 03/2000
1carboxyl radical (COO-)IBA
05/2017
1EnzymesIBA
05/2015
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
05/2015
1Messenger RNA (mRNA)IBA
05/2015
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
05/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2014
1Interleukin-2 (IL2)IBA
01/2014
1Vinblastine (Vinblastine Sulfate)FDA Link
11/2008
1Procarbazine (Matulane)FDA Link
11/2008
1Dacarbazine (DIC)FDA LinkGeneric
11/2008
1AnthracyclinesIBA
10/2008
1Proteins (Proteins, Gene)FDA Link
03/2008
1Therapeutic UsesIBA
12/2004
1Anticardiolipin AntibodiesIBA
10/2004
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
10/2004
1CladribineFDA LinkGeneric
06/2004
1Interferon-alpha (Interferon Alfa)IBA
06/2004
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2004
1MethylprednisoloneFDA LinkGeneric
10/2002
11- arabinofuranosylcytosine- 5'- stearylphosphateIBA
04/2002
1Thrombopoietin (c-mpl Ligand)IBA
06/2001
1Alanine Transaminase (SGPT)IBA
02/2001
1Transaminases (Aminotransferases)IBA
02/2001
1factor V LeidenIBA
02/2001
1IfosfamideFDA LinkGeneric
08/2000
1Asparaginase (Elspar)FDA Link
08/2000
1Carmustine (FIVB)FDA Link
08/2000
1AntibodiesIBA
07/2000
1Circular DNAIBA
05/2000

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2016 - 08/2000
5Stem Cell Transplantation
01/2016 - 08/2000
5Therapeutics
01/2014 - 03/2000
2Autologous Transplantation
12/2004 - 07/2004
1Radiotherapy
04/2013
1Hematopoietic Stem Cell Transplantation
01/2009
1Combination Drug Therapy (Combination Chemotherapy)
06/2004
1LNH 87 protocol
03/2001
1LNH87-2 protocol
08/2000